Henry Schein stock rises and outperforms competitors
Updated
Updated · MarketWatch · Apr 30
Henry Schein stock rises and outperforms competitors
6 articles · Updated · MarketWatch · Apr 30
The shares gained 1.07% to $74.59 on Thursday, while the S&P 500 rose 1.02% and the Dow Jones climbed 1.62%.
The advance ended a four-day losing streak, with Henry Schein beating flat Stryker and falling McKesson, though trailing IDEXX Laboratories, which rose 1.29%.
Henry Schein still closed 16.46% below its 52-week high of $89.29 reached on 24 February, as trading volume of 1.4 million topped its 50-day average.
With a new CEO and bold profit plan, can Henry Schein overcome fierce competition and reclaim its former stock high?
As dentistry embraces AI, can this legacy distributor truly transform its business to lead the digital revolution?